Bank Pictet & Cie (Europe)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-742
| Closed | -$348K | – | 161 |
|
2024
Q2 | $348K | Sell |
742
-296
| -29% | -$139K | 0.01% | 129 |
|
2024
Q1 | $434K | Sell |
1,038
-69
| -6% | -$28.8K | 0.01% | 137 |
|
2023
Q4 | $450K | Sell |
1,107
-42
| -4% | -$17.1K | 0.01% | 198 |
|
2023
Q3 | $400K | Sell |
1,149
-15
| -1% | -$5.22K | 0.01% | 188 |
|
2023
Q2 | $410K | Sell |
1,164
-1,159
| -50% | -$408K | 0.01% | 197 |
|
2023
Q1 | $732K | Buy |
2,323
+442
| +23% | +$139K | 0.03% | 120 |
|
2022
Q4 | $543K | Sell |
1,881
-726
| -28% | -$210K | 0.03% | 118 |
|
2022
Q3 | $755K | Sell |
2,607
-599
| -19% | -$173K | 0.04% | 109 |
|
2022
Q2 | $903K | Sell |
3,206
-1,732
| -35% | -$488K | 0.04% | 101 |
|
2022
Q1 | $1.29M | Sell |
4,938
-13,304
| -73% | -$3.47M | 0.05% | 98 |
|
2021
Q4 | $4.01M | Sell |
18,242
-555
| -3% | -$122K | 0.14% | 73 |
|
2021
Q3 | $3.41M | Sell |
18,797
-34,154
| -65% | -$6.2M | 0.13% | 77 |
|
2021
Q2 | $10.7M | Buy |
52,951
+36,560
| +223% | +$7.37M | 0.37% | 53 |
|
2021
Q1 | $3.52M | Sell |
16,391
-52,409
| -76% | -$11.3M | 0.14% | 79 |
|
2020
Q4 | $16.3M | Buy |
68,800
+18,641
| +37% | +$4.41M | 0.8% | 38 |
|
2020
Q3 | $13.6M | Buy |
+50,159
| New | +$13.6M | 0.77% | 36 |
|
2019
Q1 | – | Sell |
-4,200
| Closed | -$696K | – | 164 |
|
2018
Q4 | $696K | Buy |
+4,200
| New | +$696K | 0.14% | 70 |
|